L249-1364 Screening compound: 2-[1-(2-cyclopropyl-1,3-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide

L249-1364 Screening compound: 2-[1-(2-cyclopropyl-1,3-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide
L249-1364 Screening compound: 2-[1-(2-cyclopropyl-1,3-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L249-1364
2-[1-(2-cyclopropyl-1,3-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L249-1364

Molecular Formula

C28H33N3O4 (C28 H33 N3 O4)

Compound Name

2-[1-(2-cyclopropyl-1,3-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide

IUPAC name

2-[1-(2-cyclopropyl-13-benzoxazole-5-carbonyl)piperidin-4-yl]-N-{[4-(propan-2-yloxy)phenyl]methyl}acetamide

SMILES

CC(C)Oc1ccc(CNC(CC(CC2)CCN2C(c(cc2)cc3c2oc(C2CC2)n3)=O)=O)cc1

InChI

InChI=1S/C28H33N3O4/c1-18(2)34-23-8-3-20(4-9-23)17-29-26(32)15-19-11-13-31(14-12-19)28(33)22-7-10-25-24(16-22)30-27(35-25)21-5-6-21/h3-4,7-10,16,18-19,21H,5-6,11-15,17H2,1-2H3,(H,29,32)

InChI Key

QXVVEOGULXKJIT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27237903

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

475.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.321

Distribution Coefficient, logD

4.321

Water Solubility, LogSw

-4.25

Polar Surface Area

65.223

Acid Dissociation Constant (pKa)

13.82

Base Dissociation Constant (pKb)

0.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.40

L249-1364 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with L249-1364 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L249-1364?
Check Price and Availability of L249-1364, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L249-1364 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L249-1364
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L249-1364
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L249-1364 available by request